Featured Research

from universities, journals, and other organizations

Study Offers Insights Into Evolutionary Origins Of Life

Date:
May 18, 2001
Source:
Whitehead Institute For Biomedical Research
Summary:
In some of the strongest evidence yet to support the RNA world—an era in early evolution when life forms depended on RNA—scientists at the Whitehead Institute for Biomedical Research have created an RNA catalyst, or a ribozyme, that possesses some of the key properties needed to sustain life in such a world.

In some of the strongest evidence yet to support the RNA world—an era in early evolution when life forms depended on RNA—scientists at the Whitehead Institute for Biomedical Research have created an RNA catalyst, or a ribozyme, that possesses some of the key properties needed to sustain life in such a world.

The new ribozyme, generated by David Bartel and his colleagues at the Whitehead, can carry out a remarkably complicated and challenging reaction, especially given that it was not isolated from nature but created from scratch in the laboratory. This ribozyme can use information from a template RNA to make a third, new RNA. It can do so with more than 95 percent accuracy, and most importantly, its ability is not restricted by the length or the exact sequence of letters in the original template. The ribozyme can extend an RNA strand, adding up to 14 nucleotides, or letters, to make up more than a complete turn of an RNA helix.

These results, described in the May 18 issue of Science, suggest that RNA could have had the ability to replicate itself and sustain life in early evolution, before the advent of DNA and proteins. The findings will ultimately help evolutionary biologists address questions about how life began on earth more than three billion years ago.

Until almost two decades ago, many researchers thought that RNA was nothing more than a molecular interpreter that helps translate DNA codes into proteins. Then scientists discovered that not all enzymes were proteins—some were made of RNA. Over the past decade, they have developed techniques for producing new ribozymes in the lab, and a series of studies by the Bartel lab at the Whitehead has been lending credence to the notion of an RNA world. Still, none of the ribozymes generated by the Bartel lab or others in the field possessed the sophisticated properties needed to accurately replicate RNA. The finding reported in Science this week narrows that gap.

"Creating a complimentary strand of RNA is a challenging enzymatic reaction because it requires several things to happen at the same time. The reaction must be accurate in incorporating nucleotides based on the template strand, general enough that any template can be copied, and efficient enough to add on a large number of nucleotides," says Wendy Johnston, first author on the paper and research associate in the Bartel lab.

Theories about Life's Origins

Theories about the origins of life have long intrigued scientists and lay people alike. "A fundamental question about the origin of life is what class of molecules gave rise to some of the earliest life forms?" says Bartel.

For years, scientists debated this question, some arguing that RNA molecules were the progenitors and others arguing in favor of proteins. "It was a classic chicken-and-egg argument. RNA, like DNA, has the genetic information necessary to reproduce but needs proteins to catalyze the reaction. Conversely, proteins can catalyze reactions but cannot reproduce without the information supplied by RNA," says Bartel.

The discovery in 1982 of ribozymes bolstered the notion that RNA came before proteins, but more challenges lay ahead for evolutionary biologists before they could espouse the RNA worldview. For one, there are only eight known ribozymes in nature—no where near enough to sustain the range of reactions in an RNA world. Furthermore, compared to protein enzymes, ribozymes seemed slow and inefficient as catalysts. So scientists set out to make artificial ribozymes that were more versatile and efficient than the natural ones. If they could create such ribozymes in the lab, it would suggest that natural ones could have existed during the RNA era, but have become extinct since.

Creation and Evolution of New Ribozymes

Designing new enzymes is a difficult task, but what researchers can do is make thousands of trillions of RNA molecules, with the hope that one or a few of them can catalyze the appropriate reactions. To identify the few that have the desired properties, researchers subject the huge population of ribozymes to a test-tube evolution—a process of selection and evolution that mimics these processes in nature.

"During the selection process, we look for RNAs that can change themselves in a special way. We can then separate them from RNA that don't change themselves," says Bartel.

In 1993 Bartel and Jack Szostak at Harvard University found 65 novel ribozymes from a search of more than 1000 trillion RNAs. "When we subjected these ribozymes to a test-tube evolution, we found descendants that were 100 times more efficient," says Bartel.

Since then the Bartel lab has been using the test-tube evolution method to gather further evidence for the RNA world. Three years ago, for example, the Bartel lab found a ribozyme that could carry out the type of reaction needed to synthesize its own building blocks.

In this study, the Bartel lab took the approach again of making 1000 trillion random RNAs go through test-tube evolution to find those that could catalyze RNA formation. After successive rounds of testing, the Bartel lab isolated a ribozyme that didn't depend on a particular template sequence but could build a complimentary strand of RNA using information from any general RNA template. In fact, the ribozyme isn't hindered by longer RNA templates and works nearly as well with longer sequences as with shorter ones. This suggests that if efficiency is increased, it may be possible to replicate the entire ribozyme. The ribozyme also accurately matches bases—A to U, and C to G—to the RNA template more than 95 percent of the time, better than any previously isolated ribozyme.

"We will never be able to prove the existence of the RNA world because we can't go back in time—but we can examine the basic properties of RNA and see if these are compatible within the RNA world scenario," says Bartel.


Story Source:

The above story is based on materials provided by Whitehead Institute For Biomedical Research. Note: Materials may be edited for content and length.


Cite This Page:

Whitehead Institute For Biomedical Research. "Study Offers Insights Into Evolutionary Origins Of Life." ScienceDaily. ScienceDaily, 18 May 2001. <www.sciencedaily.com/releases/2001/05/010518083259.htm>.
Whitehead Institute For Biomedical Research. (2001, May 18). Study Offers Insights Into Evolutionary Origins Of Life. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2001/05/010518083259.htm
Whitehead Institute For Biomedical Research. "Study Offers Insights Into Evolutionary Origins Of Life." ScienceDaily. www.sciencedaily.com/releases/2001/05/010518083259.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins